Covivio (COV) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
7 Aug, 2026Opening remarks and agenda
The meeting covered the management report, corporate governance, social responsibility, auditor reports, resolutions, shareholder questions, voting, and financial agenda.
Financial performance review
Portfolio value reached €16.0bn (group share), with a diversified mix: 49% offices, 30.3% German residential, 20.7% hotels.
Net recurring income rose 10% to €526.5m, with a 6% increase per share compared to 2024.
Revenues grew 3.7% at current scope and 3.4% like-for-like, with strong occupancy rates (97.1% overall).
Financial structure strengthened: LTV at 38.9%, average debt maturity 5 years, and BBB+ rating maintained.
Stock performance outpaced benchmarks: +24.4% in 2025 and +6.2% YTD 2026.
Dividend announcements
Proposed dividend of €3.75 per share (+7% vs 2024), paid in two installments: €1.50 in March and €2.25 in July 2026.
Total dividend payout of €418.6m, with a yield of 6.4% based on April 2026 share price.
Latest events from Covivio
- Recurring net result up 7.3% in H1 2026; 4% EPS growth guidance for 2026 reaffirmed.COV
H1 2026 - Q1 2026 saw 2.5% revenue growth, high occupancy, and major Milan hotel investments.COV
Q1 2026 - Recurring net result per share up 6.4%, NAV per share up 3.9%, and 2026 targets 4% further growth.COV
H2 2025 - Revenue up 4.8% with 2025 guidance confirmed; strong operations and ESG leadership.COV
Q3 2025 - Recurring net result up 14% and 2025 guidance raised on strong growth and portfolio gains.COV
H1 2025 - Portfolio rebalanced for growth, centrality, and ESG leadership, targeting a one-third asset split.COV
CMD 2024 - Revenue up 6.8% like-for-like, occupancy at 97.3%, and €391m in disposals signed.COV
Q3 2024 - Recurring net result up 3.3%, guidance raised, and hotel exposure increased to 20%.COV
H1 2024 - Recurring earnings up 10%, hotel exposure rising, and 2025 guidance targets further growth.COV
Q4 2024